AnodyneWiki

Fenproporex

Fenproporex
Fenproporex
Salts
[]
Fenproporex hydrochloride
Fenproporex hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass188.27 g/mol [1]
Melting point146 [1]
Predicted LogP1.9 [1]
Structural Identifiers
[]
Molecular formulaC12H16N2
IUPAC name3-(1-phenylpropan-2-ylamino)propanenitrile
SMILESCC(CC1=CC=CC=C1)NCCC#N
InChIInChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3
InChIKeyIQUFSXIQAFPIMR-UHFFFAOYSA-N
CAS number16397-28-7
UNIIW0194S5FOA
PubChem CID61810
Pharmacokinetics[]
MetabolismPartly converted to amphetamine (30–60%)[3]
ExcretionUrine, mainly as amphetamine, about 5 to 9% unchanged
Routes of administrationBy mouth

Fenproporex (also known as Femproporex, Fenorex, J268.797f, 3-[(1-phenylpropan-2-yl)amino]propanenitrile, Fenproporexum, 3-((1-phenylpropan-2-yl)amino)propanenitrile, 239-772-0, 240-444-4, Desobesi or DEA No. 1575) is a prodrug and stimulant substance of the amphetamine class.

Chemistry

Salts []

Fenproporex is typically found in the form of its hydrochloride salt.

 []

Fenproporex is a racemic mixture of the (optical activity ( + / - )).

Fenproporex matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Fenproporex is an amphetamine based anorectic which is rapidly metabolized into amphetamine in the body. Both acute and chronic fenproporex administration has been shown to increase brain energy metabolism in young rats, by increasing the activity of citrate synthase, malate dehydrogenase, succinate dehydrogenase, creatine kinase and complexes I,II, III, and IV. [8] Amphetamine based drugs are also known to reduce food intake. They are addictive substances due to their ability to increase dopamine release, however their anorectic effects are believed to be a result of noradrenergic neurotransmission. Activation of the alpha 1 and beta 2 adrenoceptors has been shown to decrease food intake, and drugs which release norepinephrine or block norepinephrine reuptake can activate these receptors. [3] The alpha 1 and beta 2 adrenoceptors are noted to be clinically important receptors in weight regulation. [3] [1]

Metabolism

Fenproporex acts as a for:

Metabolic pathways []
Fenproporex

Subjective effects []

 []

  • Brazil: Fenproporex is a B2.[4]
  • Canada: Fenproporex is a Schedule IV.
  • United States: Fenproporex is a Schedule IV under the "Controlled Substances Act".
  • Germany: Fenproporex is Prescription only/Anlage III.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 61810, Fenproporex. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/61810
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fenproporex. UNII: W0194S5FOA. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/W0194S5FOA
  3. Seyffart G. Drug dosage in renal insufficiency. Springer. 1991. https://books.google.com/books?id=FubgMz6aOWAC
  4. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 09:59:47
drugspromissing (no DrugsPRO reagent data)2026-11-20 09:59:42
erowidmissing (no Erowid substance of that name)2026-11-20 09:59:43
gsrsok2026-11-20 09:59:44
hmdbmissing (hmdb.ca refused automated access to HMDB0252218)2026-11-20 09:59:42
keggok2026-11-20 09:59:44
pubchemok2026-11-20 09:59:41
redditmissing (no r/tripreports posts mention it)2026-11-20 09:59:43
sidermissing (not in SIDER)2026-11-20 09:59:42
structureok2026-11-20 09:59:42
wikipediaok2026-11-20 09:59:43